CRISPR Therapeutics AG (25) | Uncategorized (9)
Recent Contracts
-
Description of Capital Shares
(Filed With SEC on February 15, 2022)
-
Letter Agreement dated December 16, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc
(Filed With SEC on February 15, 2022)
-
Letter Agreement dated January 6, 2022, by and between CRISPR Therapeutics, Inc. and 105 W First Street Owner, L.L.C
(Filed With SEC on February 15, 2022)
-
Letter Agreement dated April 29, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc
(Filed With SEC on July 29, 2021)
-
Description of Capital Shares
(Filed With SEC on February 16, 2021)
-
Lease, dated July 24, 2020, by and between the Registrant and 105 W First Street Owner, L.L.C
(Filed With SEC on July 27, 2020)
-
Description of Capital Shares
(Filed With SEC on February 12, 2020)
-
Option Agreement, dated December 13, 2019, between CRISPR Therapeutics AG and Bayer HealthCare LLC
(Filed With SEC on February 12, 2020)
-
Open Market Sale AgreementSM, dated August 30, 2019, by and between CRISPR Therapeutics AG and Jefferies LLC
(Filed With SEC on August 30, 2019)